![Peter J. Courossi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter J. Courossi
Direttore/Membro del Consiglio presso
TRACT Therapeutics, Inc.
Profilo
Peter J.
Courossi is currently the Chief Business Officer & Director at TRACT Therapeutics, Inc. He previously held positions as Director at KeraCure, Inc., Principal at Millennium Pharmaceuticals, Inc. and TransForm Pharmaceuticals, Inc., Chief Financial Officer at Sention, Inc., Acceleron Pharma, Inc., Alinea Pharmaceuticals, Inc., Visterra, Inc., AVEO Pharmaceuticals, Inc., Genzyme Tissue Repair, and Civitas Therapeutics, Inc. Courossi earned an MBA from Babson College.
Posizioni attive di Peter J. Courossi
| Società | Posizione | Inizio |
|---|---|---|
TRACT Therapeutics, Inc.
 TRACT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops revolutionary therapeutic cells | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Peter J. Courossi
| Società | Posizione | Fine |
|---|---|---|
| VISTERRA INC | Direttore Finanziario/CFO | 02/12/2013 |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Direttore Finanziario/CFO | - |
TransForm Pharmaceuticals, Inc.
 TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | - |
Genzyme Tissue Repair
 Genzyme Tissue Repair BiotechnologyHealth Technology Developes biological products and devices for orthopedic injuries | Corporate Officer/Principal | - |
Formazione di Peter J. Courossi
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
12
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
KeraCure, Inc.
 KeraCure, Inc. Medical DistributorsDistribution Services Develops and manufactures health care products | Distribution Services |
Sention, Inc.
 Sention, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Alinea Pharmaceuticals, Inc.
 Alinea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for diabetes and related metabolic disorders | Health Technology |
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
Genzyme Tissue Repair
Genzyme Tissue Repair BiotechnologyHealth Technology Developes biological products and devices for orthopedic injuries | Health Technology |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Health Technology |
TRACT Therapeutics, Inc.
TRACT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops revolutionary therapeutic cells | Commercial Services |
